YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. entered a deal to produce Gilead Sciences Inc.’s remdesivir drug at a plant in McPherson, Kansas.
There's been a shortage of remdesivir after the Food and Drug Administration gave emergency authorization for its use as treatment for COVID-19 patients.
Financial terms of the multiyear deal were not disclosed.
Read more from the Kansas City Business Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach